CI · Cigna Group
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted income from operations non-GAAP | $15.58 | six months ended June 30 | — |
|
|
|||
| Adjusted Income from Operations, per share non-GAAP | $7.78 | Second quarter 2026 | — |
|
|
|||
| adjusted SG&A expense ratio non-GAAP | 4.6% | Second quarter 2026 | — |
|
|
|||
| Behavioral Care | 27.62M | As of June 30, 2026 | — |
| Cigna Healthcare MCR | 84.5% | Second quarter 2026 | — |
| Dental | 18.49M | As of June 30, 2026 | — |
| International Health | 1.74M | As of June 30, 2026 | — |
| SG&A expense ratio | 4.8% | Second quarter 2026 | — |
|
|
|||
| Total Customer Relationships | 182.77M | As of June 30, 2026 | — |
| Total Medical Customers | 18.41M | As of June 30, 2026 | — |
| Total Pharmacy Customers | 118.24M | As of June 30, 2026 | — |
| U.S. Healthcare | 16.68M | As of June 30, 2026 | — |
| debt-to-capitalization ratio | 42.3% | March 31, 2026 | — |
| Adjusted Revenues non-GAAP | $274.65B | Year Ended December 31, 2025 | — |
| Shares repurchased | 11.9M | Year Ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Healthcare Plans — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CI
this stock
Cigna Group
|
$74.37B | +0.8% | +11.2% | 11.7 | 1.8% |
|
UNH
Unitedhealth Group Inc
|
$353.59B | +19.3% | +11.8% | — | 1.7% |
|
CVS
CVS HEALTH Corp
|
$119.95B | +18.0% | +7.8% | 24.8 | 1.5% |
|
ELV
Elevance Health, Inc.
|
$87.01B | +13.7% | +12.5% | 17.8 | 2.6% |
|
HUM
Humana Inc
|
$45.39B | +49.1% | +10.1% | 40.3 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CI | +0.0% | -2.6% | -3.9% | -0.6% | +0.8% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | +0.4% | -5.2% | -14.7% | -3.3% | -11.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.